Salman Hoda
On June 11, 2022, the board of directors of Agentix Corp. (the “Company”) appointed Salman Hoda as a member of the board of directors of the Company.
Highest-materiality recent filing
Agentix Corp. appoints Salman Hoda to board of directors
Salman Hoda appointed to board on June 11, 2022; also serves as Secretary and Treasurer since Dec 2020.
Agentix and RTI announce worldwide exclusive license for NAFLD, NASH, T2D, obesity candidates
License covers RTI small-molecule candidates for NAFLD, NASH, T2D, and obesity.
Agentix Corp. completes merger with Applied Biopharma LLC; interests converted to common stock
Merger completed July 14, 2021: AB Merger LLC merged into Applied Biopharma, with Applied Biopharma surviving.
Agentix corrects prior filing; enters merger to make Applied BioPharma wholly-owned sub
Corrects May 27, 2021 8-K to clarify Applied BioPharma was not then a wholly-owned subsidiary.
On June 11, 2022, the board of directors of Agentix Corp. (the “Company”) appointed Salman Hoda as a member of the board of directors of the Company.
Max materiality 0.65 · Median 0.45 · Most common event m_and_a